正邦科技(002157.SZ)8月生豬銷售收入38.70億元 同比增長534.65%
格隆匯 9 月 6日丨正邦科技(002157.SZ)發佈公告,公司2020年8月銷售生豬107.12萬頭(其中仔豬40.92萬頭,商品豬66.20萬頭),環比增長17.47%,同比增長232.93%;銷售收入38.70億元,環比增長23.67%,同比增長534.65%。商品豬(扣除仔豬後)銷售均價36.30元/公斤,較上月下降0.87%;均重131.43公斤/頭,較上月增長3.94%。
2020年1-8月,公司累計銷售生豬470.84萬頭,同比上升18.47%;累計銷售收入177.11億元,同比增長193.93%。
公告表示,2020年8月,公司生豬銷售數量和銷售收入同比增幅較大主要是由於生豬產能釋放和銷售價格增幅較大所致。今年1-8月,公司生豬累積銷售收入同比增長較大主要是由於生豬銷售價格增幅較大所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.